3β-20β-dihydroxy-5α-pregnane (UC1011) antagonism of the GABA potentiation and the learning impairment induced in rats by allopregnanolone.
Şahruh Turkmen; Per Lundgren; Vita Birzniece; Ewa Zingmark; Torbjörn Backstrom; Inga-Maj Johansson
European Journal of Neuroscience2004
Summary (paraphrased)
The 3β-steroid UC1011 blocks both the GABA-potentiating and the learning-impairing effects of allopregnanolone in rats. As a functional antagonist of allopregnanolone at the GABA-A receptor, it demonstrates that neurosteroid signaling can be pharmacologically opposed without blocking GABA itself. The compound is the direct conceptual ancestor of isoallopregnanolone (sepranolone), later developed for premenstrual dysphoric disorder. Included here strictly as a mechanistic research record, it is the founding preclinical demonstration of a neurosteroid-antagonist strategy.
Why it’s in the systems review
If excess neurosteroid signaling is causal, then blocking it is the logical therapeutic probe; UC1011 is the founding demonstration that allopregnanolone's effects can be selectively antagonized. Its lineage runs to isoallopregnanolone/sepranolone, the clinical-stage neurosteroid antagonist — a genuine treatment-candidate anchor recorded here as mechanistic research only. It also shows the field already accepts that allopregnanolone excess can be pathogenic (in PMDD), a precedent for extending the logic to post-drug syndromes.